RecruitingPhase 1NCT07085975

The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges


Sponsor

McMaster University

Enrollment

33 participants

Start Date

Aug 5, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The inhalation of adenosine 5'-triphosphate (ATP) to evoke cough (ATP cough challenge) is becoming increasingly used as a tool to measure cough hypersensitivity in patients with chronic cough. However, the safety, feasibility, and repeatability of this procedure is not widely known. In this study, we will perform ATP cough challenges in healthy individuals and in patients with mild asthma and chronic cough to better understand the safety, feasibility, and repeatability of these challenges. Such information will guide the future conduct of ATP cough challenges to measure cough hypersensitivity and identify patients who may better respond to ATP-blocking therapies.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether inhaling a substance called ATP (a natural energy molecule found in cells) can safely trigger coughing, and whether this test can be reliably repeated — which could help doctors better study and treat chronic cough. Healthy adults are tested first, then patients with chronic cough. **You may be eligible if...** - You are 18 or older - For the first phase: you are a healthy adult with normal lung function and no history of chronic cough or breathing problems - For later phases: you have chronic cough or another respiratory condition being studied **You may NOT be eligible if...** - You are a smoker or have a significant smoking history (more than 5 pack-years within the last 6 months) - You have had a recent respiratory infection within 6 weeks - You cannot perform reliable lung function tests - You are taking certain medications that affect coughing (such as ACE inhibitors) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAdenosine 5'-triphosphate

Participants will inhale increasing doubling concentrations of adenosine 5'-triphosphate dissolved in 0.9% saline through the Aerogen Solo vibrating mesh nebulizer.


Locations(1)

Respiratory Research Lab

Hamilton, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07085975


Related Trials